S-T segment voltage during sequential coronary occlusions is an unreliable marker of preconditioning.

During coronary angioplasty, a stair-step decrease in peak S-T segment elevation from the first to the second coronary occlusion has been assumed to indicate a preconditioning (PC) effect. This association was evaluated with myocardial electrograms in rabbits, which revealed that two sequential 5-min coronary occlusions resulted in a marked decrease in the area under the S-T segment voltage-time curve (P < 0.05) with no change during a third occlusion. Pretreatment with either 5-hydroxydecanoate, a mitochondrial ATP-sensitive potassium (K(ATP)) channel blocker, or anisomycin, an activator of stress-activated protein kinases, had no effect on the stair-step decline in the S-T segment voltage between the first two occlusions. HMR-1883, a potent closer of sarcolemmal K(ATP) channels, abolished changes in S-T segment elevation after brief coronary occlusions but had no effect on the infarct-sparing property of the two preconditioning 5-min occlusions. Interestingly, HMR-1883 blocked myocardial protection from diazoxide, raising doubt that the latter opens only mitochondrial channels. Therefore, myocardial protection and S-T segment changes during ischemia are dissociated. These data suggest that it is the mitochondrial K(ATP) channel that protects the myocardium, and it is the sarcolemmal channel that is responsible for changes in S-T elevation. Therefore, it cannot always be inferred that changes in S-T segment elevation reflect the state of myocardial protection.

[1]  F. Crea,et al.  Ischemic preconditioning in humans: models, mediators, and clinical relevance. , 1999, Circulation.

[2]  J. Downey,et al.  Ischemic preconditioning depends on interaction between mitochondrial KATP channels and actin cytoskeleton. , 1999, The American journal of physiology.

[3]  B. Schölkens,et al.  HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. Part I: effects on cardiomyocytes, coronary flow and pancreatic beta-cells. , 1998, The Journal of pharmacology and experimental therapeutics.

[4]  Yongge Liu,et al.  Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? , 1998, Circulation.

[5]  J. Downey,et al.  Protein tyrosine kinase is downstream of protein kinase C for ischemic preconditioning's anti-infarct effect in the rabbit heart. , 1998, Journal of molecular and cellular cardiology.

[6]  M. Smith,et al.  Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection. , 1997, Circulation research.

[7]  J. Downey,et al.  Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart. , 1997, Journal of molecular and cellular cardiology.

[8]  J. Woodgett,et al.  Mammalian Mitogen-activated Protein Kinase Pathways Are Regulated through Formation of Specific Kinase-Activator Complexes* , 1996, The Journal of Biological Chemistry.

[9]  N. Maulik,et al.  Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts , 1996, FEBS letters.

[10]  N. Maulik,et al.  Preconditioning Potentiates Molecular Signaling for Myocardial Adaptation to Ischemia a , 1996, Annals of the New York Academy of Sciences.

[11]  R. Kloner,et al.  Progressive decrease in the ST segment elevation during ischemic preconditioning: is it related to recruitment of collateral vessels? , 1996, Journal of molecular and cellular cardiology.

[12]  J. Downey,et al.  Electrophysiological characteristics of repetitive ischemic preconditioning in the pig heart. , 1996, Journal of molecular and cellular cardiology.

[13]  F. Crea,et al.  Effects of A1 adenosine receptor blockade by bamiphylline on ischaemic preconditioning during coronary angioplasty. , 1996, European heart journal.

[14]  V. Yarov-Yarovoy,et al.  The Mitochondrial K Channel as a Receptor for Potassium Channel Openers (*) , 1996, The Journal of Biological Chemistry.

[15]  R. Kerensky,et al.  The effects of intracoronary adenosine on preconditioning during coronary angioplasty , 1995, Clinical cardiology.

[16]  F. Crea,et al.  Ischemic Preconditioning During Coronary Angioplast Is Prevented by Glibenclamide, a Selective ATP‐Sensitive K+ Channel Blocker , 1994, Circulation.

[17]  J Ludbrook,et al.  Repeated measurements and multiple comparisons in cardiovascular research. , 1994, Cardiovascular research.

[18]  C. Toombs,et al.  Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamide. , 1993, Cardiovascular research.

[19]  G. Grover,et al.  Role of Myocardial ATP‐Sensitive Potassium Channels in Mediating Preconditioning in the Dog Heart and Their Possible Interaction With Adenosine A1‐Receptors , 1992, Circulation.

[20]  J. Downey,et al.  Intravenous Pretreatment With A1‐Selective Adenosine Analogues Protects the Heart Against Infarction , 1992, Circulation.

[21]  G. Gross,et al.  Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. , 1992, Circulation research.

[22]  G. Grover,et al.  Specific block of the anti-ischemic actions of cromakalim by sodium 5-hydroxydecanoate. , 1991, Circulation research.

[23]  W. Laskey,et al.  Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features. , 1990, Circulation.